Kalos Therapeutics, Inc. announced it raised $100,000 in an initial filing from an offering of $2.4 Million

Jan 07, 2016•almost 10 years ago

Amount Raised

$100,000

Round Type

pre-seed

CaliforniaHealthcare

Company Information

Company

Kalos Therapeutics, Inc.

Location

California, United States

About

Kalos Therapeutics develops atrial natriuretic peptides for the treatment of cancer.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech